
Cerenome, Inc. (CNSY)
Last updated: 2026-10-28 15:43:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Cerenome, Inc. (CNSY) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1.71, with a market capitalization of $11.92M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.49 to $4.16. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$11.92M | |
$1.71 | |
$4.16 | |
$1.49 | |
$1.66 | |
15.80K | |
112.12K | |
-- | |
$4.16 | |
$1.49 | |
-- | |
-- |
Cerenome, Inc. (CNSY) Stock Price Today
Cerenome, Inc. (CNSY) is currently trading at $1.71 as of 2026-10-28 15:41:00, up 2.71% ($0.05) from the previous close of $1.66
During today's regular trading session, CNSY has traded between $1.49 and $4.16, with a trading volume of 15.80K shares. The current price is near the lower end of today's range.
Cerenome, Inc. (CNSY) 7-Day Stock Price Change
Over the past seven days, Cerenome, Inc. (CNSY) moved from $1.65 to $1.71, representing a gain of 3.33% ($0.06).
The stock traded between $1.51 and $1.84 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 58.43 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
CNSY 52-Week Price Position
Position in Range: 8.2%
CNSY is currently trading at $1.71, placing it 8.2% of the way from its 52-week low of $1.49 to its 52-week high of $4.16. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Cerenome, Inc. (CNSY)?
Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.
Cerenome, Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 28 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Cerenome, Inc. (CNSY) Stock on MEXC
Eligible investors can buy real shares of Cerenome, Inc. (CNSY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Cerenome, Inc. (CNSY) stock price today?
2.Is CNSY stock going up or down today?
3.What is CNSY pre-market price?
4.What is CNSY after-hours price?
5.Is CNSY stock trading now?
6.Where does CNSY sit relative to its 52-week high and low?
7.What sector is Cerenome, Inc. in?
8.What is Cerenome, Inc.'s market capitalization and where is it listed?
9.How is CNSY valued in terms of P/E ratio and EPS?
10.Does Cerenome, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
CNSY Stock Calculator
Estimate the value between CNSY shares and USD.
CNSY Shares to USD
1.00 CNSY shares = 1.705 USD
Calculations are estimates based on the latest available price and are for reference only.

